Volta Labs launches fully automated, PCR-free workflow for whole genome sequencing

▴ Volta Labs launches
The automated, PCR-free workflow for whole genome sequencing (WGS) is set to revolutionize clinical research by reducing amplification bias, minimizing manual errors, and enhancing coverage in challenging GC-rich regions. This push-button solution boosts reproducibility, increases efficiency by 75–80% for laboratory staff, and makes high-quality, clinical-grade WGS accessible to mid-throughput laboratories.

At the Advances in Genome Biology and Technology (AGBT) General Meeting 2026, Volta Labs, a leader in next-generation sequencing (NGS) automation, has launched the Callisto Complete Kit for DNA EF Library Prep, a fully automated, PCR-free workflow for whole genome sequencing.

 

The new solution combines Watchmaker Genomics’ high-performance NGS chemistry with Volta’s digital fluidics platform, enabling labs to eliminate manual liquid handling, reduce operator variability, and generate reproducible, high-quality WGS libraries with minimal staffing burden.

 

Watchmaker Genomics Collaboration

As part of its product evolution, Volta Labs also introduced the Callisto™ Complete Kit for DNA EF Library Prep, Powered by Watchmaker Genomics. The fully automated solution delivers PCR-free whole genome sequencing with minimal hands-on time, high reproducibility, and strong performance across challenging inputs.

This launch represents a major step forward in making highest quality WGS accessible without increasing staffing burden or workflow complexity.

With new collaborations spanning Roche and Watchmaker Genomics™ Volta Labs is expanding the capabilities of its Callisto™ platform — transforming sequencing from manual workflow development to true push-button execution.

 

The Shift to Apps-Based Genomics

Volta Labs also unveiled a growing pipeline of pre-developed applications rolling out through 2026 — advancing its vision of an apps-based model for genomics, where validated workflows replace repeated, costly method development.

"Sequencing innovation shouldn't require every lab to reinvent the workflow," said Udayan Umapathi, CEO of Volta Labs. "We're accelerating the industry's shift toward truly automated genomics — where push-button sequencing becomes the standard, not the exception."

Tags : #BiotechInnovation #LifeSciences #PrecisionMedicine #ResearchInnovation #GeneticResearch #MolecularBiology #LabAutomation #smitakumar #medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

How Population Health Dashboards Support Better Resource PlanningOctober 15, 2026
Why Health Data Quality Matters for Public Health PlanningOctober 15, 2026
School Students Argue the Limits of AI Surveillance at National Moot Court Hosted by BML Munjal UniversityOctober 14, 2026
UAE investment drives Middle East biopharma transformation as precision medicine set for double-digit growthOctober 14, 2026
VS Hospitals’ Third Super-Speciality Hospital Inaugurated in North ChennaiOctober 13, 2026
20 Years with a ‘Bent Back’: Fortis Hospital Rajajinagar Corrects Severe 70-Degree Spinal Deformity in 60-Year-OldOctober 13, 2026
Ketto Supports Fundraiser to Help Prakash Battle Rare Cancer, Family Seeks ₹3 Crore for TreatmentOctober 13, 2026
Shaping the Future of Global Health: 'Go Healthy with Taiwan 2026' Unveils Top 20 Innovators from 62 NationsOctober 13, 2026
Hospital Brand Reputation: Building Trust in Indian HealthcareOctober 13, 2026
Healthcare Leadership in the AI Age: Skills for Hospital CEOsOctober 13, 2026
Max Smart Super Speciality Hospital, Saket, Performs Complex Lung-Preserving Surgery on Kenyan Patient with Rare Lung CancerOctober 12, 2026
Fortis Escorts, New Delhi Introduces AI-Powered, Robot-Assisted Hybrid Cath Lab, Advancing the Future of Complex Cardiac and Vascular Care October 12, 2026
50% OF CHILDREN STARTING THERAPY AT SUNSHINE BY LISSUN ARE UNDER FIVE, REPORT SHOWS October 12, 2026
Can Liver Cancer Develop Without Symptoms? The Silent Signs You Should KnowOctober 12, 2026
Ramkrishna CARE Cancer Institute Lights Up in Pink for Breast Cancer AwarenessOctober 12, 2026
The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026